HealthTech: Early stage Alzheimer’s | Detecting diseases more quickly
September 8, 2021
PITTSBURGH, PA—Researchers from the University of Pittsburgh have just completed a study involving living patients that may bring hope to those with Alzheimer’s. The study findings suggest that targeting neuroinflammation might be beneficial for people with early-stage Alzheimer’s disease and that it might help reverse or at least slow down the accumulation of pathologic tau protein in the brain and stave off dementia.
ROCHESTER, MN—The Mayo Clinic is teaming up with Alphabet’s life science subsidiary Verily to develop a digital point-of-care clinical decision support tool. The goal is for clinicians to tap into a number of data resources from Mayo Clinic-approved sources and de-identified health record data.
WEST LAYFAYETTE, IN—Life sciences company Amplified Sciences, which is developing diagnostics designed to detect debilitating diseases more quickly, has closed on an $1.8 million seed round. Investors include Chicago-based OCA Ventures, Purdue Ventures, Indiana University Ventures, the IU Angel Network, New York-based Golden Seeds, Houston Angel Network, Chemical Angel Network in California, and Gravity Ventures in Indianapolis.
